Improved Survival of Diabetic Foot Ulcer Patients 1995–2008
Open Access
- 1 November 2008
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (11), 2143-2147
- https://doi.org/10.2337/dc08-1242
Abstract
OBJECTIVE—The purpose of this study was to determine whether a strategy of aggressive cardiovascular risk management reduced the mortality associated with diabetic foot ulceration. RESEARCH DESIGN AND METHODS—After an initial audit of outcomes demonstrating a high mortality rate in 404 diabetic foot ulcer patients with the first ulceration developing between 1995 and 1999, a new aggressive cardiovascular risk policy was introduced as standard practice at the Diabetic Foot Clinic, Royal Infirmary of Edinburgh, in 2001. In the first 3 years of this policy, 251 patients were screened and identified. The audit cycle was then closed by reauditing the 5-year mortality for this second group of foot ulcer patients in 2008. RESULTS—Overall 5-year mortality was reduced from 48.0% in cohort 1 to 26.8% in cohort 2 (P < 0.001). Improvement in survival was seen for both neuroischemic patients (5-year mortality of 58% reduced to 36%; relative reduction 38%) and neuropathic patients (36% reduction to 19%; relative reduction 47%) (both P < 0.001). Patients were more likely to die if they were older at the time of ulceration or had type 2 diabetes, renal impairment, or preexisting cardiovascular disease or were already taking aspirin. Prior statin use, current smoker or ex-smoker status, blood pressure, A1C, and total cholesterol were not significantly different between survivors and those who died in the follow-up periods. CONCLUSIONS—Diabetic foot ulcer patients have a high risk of death. Survival has improved over the past 13 years. The adoption of an aggressive cardiovascular risk management policy in diabetic foot ulcer clinics is recommended for these patients.Keywords
This publication has 26 references indexed in Scilit:
- Explaining the Decline in Early Mortality in Men and Women With Type 2 DiabetesDiabetes Care, 2008
- Long-Term Outcome and Disability of Diabetic Patients Hospitalized for Diabetic Foot UlcersDiabetes Care, 2008
- Antiplatelet drug use in a diabetic clinicQJM: An International Journal of Medicine, 2007
- Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom studyDiabetic Medicine, 2005
- Changing aspirin use in patients with Type 2 diabetes in the UKPDSDiabetic Medicine, 2004
- Does aggressive statin therapy offer improved cholesterol-independent benefits compared to conventional statin treatment?International Journal of Cardiology, 2004
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996